Publications

  1. Asbury K, Blair JE, August J, Beatty NL, Mi L, Carey EJ, Huskey JL, LeMond LM, Zangeneh TT. De novo coccidioidomycosis among solid organ transplant recipients 1 or more years after transplant. Am J Transplant. 2019 Sep; 19 (9):2517-2524 Epub 2019 Mar 26
    View PubMed
  2. Lai JC, Sonnenday CJ, Tapper EB, Duarte-Rojo A, Dunn MA, Bernal W, Carey EJ, Dasarathy S, Kamath BM, Kappus MR, Montano-Loza AJ, Nagai S, Tandon P. Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice. Am J Transplant. 2019 Jul; 19 (7):1896-1906 Epub 2019 May 08
    View PubMed
  3. Carey EJ, Lai JC, Sonnenday C, Tapper EB, Tandon P, Duarte-Rojo A, Dunn MA, Tsien C, Kallwitz ER, Ng V, Dasarathy S, Kappus M, Bashir MR, Montano-Loza AJ. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation. Hepatology. 2019 Jun 20 Epub 2019 June 20
    View PubMed
  4. Yokoda RT, Carey EJ. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. Am J Gastroenterol. 2019 Jun 4 Epub 2019 June 04
    View PubMed
  5. Kuo SZ, Ahmad M, Dunn MA, Montano-Loza AJ, Carey EJ, Lin S, Moghe A, Chen HW, Ebadi M, Lai JC. Sarcopenia Predicts Posttransplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation. Transplantation. 2019 Apr 8 Epub 2019 Apr 08
    View PubMed
  6. Chascsa DM, Lai JC, Dunn MA, Montano-Loza AJ, Kappus MR, Dasarathy S, Carey EJ. Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation. Dig Dis Sci. 2018 Dec; 63 (12):3290-3296 Epub 2018 Sept 03
    View PubMed
  7. Ebadi M, Wang CW, Lai JC, Dasarathy S, Kappus MR, Dunn MA, Carey EJ, Montano-Loza AJ, From the Fitness, Life Enhancement, and Exercise in Liver Transplantation (FLEXIT) Consortium. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis. J Cachexia Sarcopenia Muscle. 2018 Dec; 9 (6):1053-1062 Epub 2018 Sept 29
    View PubMed
  8. McNally BB, Carey EJ. Objective Versus Subjective Assessment of Functional Status in Candidates for Liver Transplantation. Transplant Proc. 2018 Dec; 50 (10):3508-3512 Epub 2018 June 22
    View PubMed
  9. Adike A, Carey EJ, Lindor KD. Primary sclerosing cholangitis in children versus adults: lessons for the clinic. Expert Rev Gastroenterol Hepatol. 2018 Oct; 12 (10):1025-1032 Epub 2018 Oct 01
    View PubMed
  10. Mayo MJ, Wigg AJ, Leggett BA, Arnold H, Thompson AJ, Weltman M, Carey EJ, Muir AJ, Ling L, Rossi SJ, DePaoli AM. NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Hepatol Commun. 2018 Sep; 2 (9):1037-1050 Epub 2018 Aug 30
    View PubMed
  11. Aguilar MT, Carey EJ. Current Status of Liver Transplantation for Primary Biliary Cholangitis. Clin Liver Dis. 2018 Aug; 22 (3):613-624
    View PubMed
  12. Hilscher MB, Tabibian JH, Carey EJ, Gostout CJ, Lindor KD. Dominant strictures in primary sclerosing cholangitis: A multicenter survey of clinical definitions and practices. Hepatol Commun. 2018 Jul; 2 (7):836-844 Epub 2018 May 04
    View PubMed
  13. Ali AH, Tabibian JH, Nasser-Ghodsi N, Lennon RJ, DeLeon T, Borad MJ, Hilscher M, Silveira MG, Carey EJ, Lindor KD. Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis. Hepatology. 2018 Jun; 67 (6):2338-2351 Epub 2018 Apr 19
    View PubMed
  14. Levy C, Bowlus CL, Carey E, Crawford JM, Deane K, Mayo MJ, Kim WR, Fried MW. A real-world observational cohort of patients with primary biliary cholangitis: TARGET-primary biliary cholangitis study design and rationale. Hepatol Commun. 2018 May; 2 (5):484-491 Epub 2018 Mar 23
    View PubMed
  15. Damman JL, Rodriguez EA, Ali AH, Buness CW, Cox KL, Carey EJ, Lindor KD. Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis. Aliment Pharmacol Ther. 2018 Apr; 47 (7):886-895 Epub 2018 Feb 07
    View PubMed
  16. Kahn A, Horsley-Silva JL, Lam-Himlin DM, Reeder CB, Douglas DD, Carey EJ. Ibrutinib-induced acute liver failure. Leuk Lymphoma 2018 Feb; 59 (2):512-514 Epub 2017 July 11
    View PubMed
  17. Hu RW, Carey EJ, Lindor KD, Tabibian JH. Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications. Ann Hepatol. 2017 Nov - Dec; 16 (6):835-841
    View PubMed
  18. Hu RW, Carey EJ, Lindor KD, Tabibian JH. Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications. Ann Hepatol. 2017 Oct 16; 16 (6):835-841
    View PubMed
  19. Bhanji RA, Carey EJ, Yang L, Watt KD. The Long Winding Road to Transplant: How Sarcopenia and Debility Impact Morbidity and Mortality on the Waitlist. Clin Gastroenterol Hepatol. 2017 Oct; 15 (10):1492-1497 Epub 2017 Apr 08
    View PubMed
  20. Bhanji RA, Carey EJ, Watt KD. Review article: maximising quality of life while aspiring for quantity of life in end-stage liver disease. Aliment Pharmacol Ther. 2017 Jul; 46 (1):16-25 Epub 2017 May 02
    View PubMed
  21. Carey EJ, Lai JC, Wang CW, Dasarathy S, Lobach I, Montano-Loza AJ, Dunn MA, Fitness, Life Enhancement, and Exercise in Liver Transplantation Consortium. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl. 2017 May; 23 (5):625-633
    View PubMed
  22. Rodriguez EA, Carey EJ, Lindor KD. Emerging treatments for primary sclerosing cholangitis. Expert Rev Gastroenterol Hepatol. 2017 May; 11 (5):451-459 Epub 2017 Feb 22
    View PubMed
  23. Chascsa D, Carey EJ, Lindor KD. Old and new treatments for primary biliary cholangitis. Liver Int. 2017 Apr; 37 (4):490-499
    View PubMed
  24. Adike A, Rakela J, Czaplicki C, Moss A, Carey E. Right Hepatic Lobe Resection and Thrombocytopenia. Ann Hepatol. 2017 Jan - Feb; 16 (1):10-11
    View PubMed
  25. Ali AH, Carey EJ, Lindor KD. The Microbiome and Primary Sclerosing Cholangitis. Semin Liver Dis. 2016 Sep; 36 (4):340-348 Epub 2016 Dec 20
    View PubMed
  26. Horsley-Silva JL, Carey EJ, Lindor KD. Advances in primary sclerosing cholangitis. Lancet Gastroenterol Hepatol. 2016 Sep; 1 (1):68-77 Epub 2016 Aug 10
    View PubMed
  27. Kahn A, Agrwal N, Carey EJ, Madura JA 2nd, Hewitt WR Jr, Lambert KL, Grys TE, Vikram HR. Gastric lap-band infection due to Mycobacterium abscessus presenting as new-onset ascites in a cirrhotic patient. Infect Dis (Lond). 2016 Aug; 48 (8):632-5 Epub 2016 May 25
    View PubMed
  28. Kahn A, Reynolds JA, Chakkera HA, Aqel BA, Byrne TJ, Douglas DD, Moss AA, Vargas HE, Carey EJ. Prospective Analysis of Metabolic Parameters in the Detection of Diabetes and Metabolic Syndrome in Liver Transplant Recipients. Metab Syndr Relat Disord. 2016 Aug; 14 (6):305-10 Epub 2016 May 10
    View PubMed
  29. Adike A, Karlin N, Menias C, Carey EJ. Pseudocirrhosis: A Case Series and Literature Review. Case Rep Gastroenterol. 2016 May-Aug; 10 (2):381-391 Epub 2016 July 29
    View PubMed
  30. Hilscher M, Enders FB, Carey EJ, Lindor KD, Tabibian JH. Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis. Ann Hepatol. 2016 Mar-Apr; 15 (2):246-53
    View PubMed
  31. Werner KT, Mackey PA, Castro JC, Carey EJ, Chakkera HA, Cook CB. Hyperglycemia during the immediate period following liver transplantation. Future Sci OA. 2016 Mar; 2 (1):FSO97 Epub 2016 Jan 27
    View PubMed
  32. Hilscher M, Enders FB, Carey EJ, Lindor KD, Tabibian JH. Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis. Ann Hepatol. 2016 Mar - Apr; 15 (2):246-253
    View PubMed
  33. Ali AH, Tabibian JH, Carey EJ, Lindor KD. Emerging drugs for the treatment of Primary Biliary Cholangitis. Expert Opin Emerg Drugs. 2016 Feb 22;
    View PubMed
  34. Ali AH, Tabibian JH, Carey EJ, Lindor KD. Emerging drugs for the treatment of primary biliary cholangitis Expert Opinion On Emerging Drugs. 2016 Jan 2; 21: (1)39-56.
  35. Ali AH, Carey EJ, Lindor KD. The management of autoimmunity in patients with cholestatic liver diseases. Expert Rev Gastroenterol Hepatol. 2016; 10: (1)73-91.
    View PubMed
  36. Ali AH, Carey EJ, Lindor KD. Targets and investigative treatments for primary biliary cholangitis Expert Opinion on Orphan Drugs. 2016; 4: (10)1011-20.
  37. Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015 Oct 17; 386(10003):1565-75. Epub 2015 Sep 11.
    View PubMed
  38. Kahn A, Carey EJ, Blair JE. Universal fungal prophylaxis and risk of coccidioidomycosis in liver transplant recipients living in an endemic area. Liver Transpl. 2015 Mar; 21: (3)353-61.
    View PubMed
  39. Ali AH, Carey EJ, Lindor KD. Current research on the treatment of primary sclerosing cholangitis. Intractable Rare Dis Res. 2015 Feb; 4 (1):1-6
    View PubMed
  40. Yadav A, Chang YH, Carpenter S, Silva AC, Rakela J, Aqel BA, Byrne TJ, Douglas DD, Vargas HE, Carey EJ. Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates. Clin Transplant. 2015 Feb; 29(2):134-41. Epub 2015 Jan 09.
    View PubMed
  41. Ali AH, Carey EJ, Lindor KD. Recent advances in the development of farnesoid X receptor agonists. Ann Transl Med. 2015 Jan; 3 (1):5
    View PubMed
  42. Gallegos-Orozco JF, Silva AC, Batheja MJ, Chang YH, Hansen KL, Lam-Himlin D, De Petris G, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan DC, Silva AM, Rakela J, Vargas HE. Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Abdom Imaging. 2014 Dec 02.
    View PubMed
  43. Ali AH, Carey EJ, Lindor KD. Diagnosis and management of primary biliary cirrhosis. Expert Rev Clin Immunol. 2014 Dec; 10(12):1667-78. Epub 2014 Nov 10.
    View PubMed
  44. Corey RL, Whitaker MD, Crowell MD, Keddis MT, Aqel B, Balan V, Byrne T, Carey E, Douglas DD, Harrison ME, Vargas HE, Rakela J. Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation. Clin Transplant. 2014 May; 28 (5):579-84 Epub 2014 Apr 21
    View PubMed
  45. Carey EJ. Sarcopenia in solid organ transplantation. Nutr Clin Pract. 2014 Apr; 29(2):159-70. Epub 2014 Feb 14.
    View PubMed
  46. Ronan BA, Agrwal N, Carey EJ, De Petris G, Kusne S, Seville MT, Blair JE, Vikram HR. Fulminant hepatitis due to human adenovirus. Infection. 2014 Feb; 42 (1):105-11 Epub 2013 Aug 24
    View PubMed
  47. Ali AH, Carey EJ, Lindor KD. An overview of current and future therapeutic strategies for the treatment of primary sclerosing cholangitis. Expert Opinion on Orphan Drugs. 2014; 2(6):545-56.
  48. Carey EJ, Iyer VN, Nelson DR, Nguyen JH, Krowka MJ. Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency-related cirrhosis. Liver Transpl. 2013 Dec; 19: (12)1370-6.
    View PubMed
  49. Werner KT, Sando S, Carey EJ, Vargas HE, Byrne TJ, Douglas DD, Harrison ME, Rakela J, Aqel BA. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci. 2013 Jun; 58 (6):1776-80 Epub 2013 Jan 12
    View PubMed
  50. Vucicevic D, Carey EJ, Karlin NJ. Trastuzumab-induced hepatotoxicity: a case report. Breast Care (Basel). 2013 May; 8 (2):146-8
    View PubMed
  51. Carey EJ, Mayer AP, Files JA. Tired of being tired. J Womens Health (Larchmt). 2013 Mar; 22(3):289-90. Epub 2013 Feb 21.
    View PubMed
  52. Yadav A, Carey EJ. Osteoporosis in chronic liver disease. Nutr Clin Pract. 2013 Feb; 28(1):52-64. Epub 2012 Dec 20.
    View PubMed
  53. Yadav AD, Chang YH, Aqel BA, Byrne TJ, Chakkera HA, Douglas DD, Mulligan DC, Rakela J, Vargas HE, Carey EJ. New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database. J Transplant. 2013; 2013:269096 Epub 2013 Sept 24
    View PubMed
  54. Hsieh TH, Mekeel KL, Crowell MD, Nguyen CC, Das A, Aqel BA, Carey EJ, Byrne TJ, Vargas HE, Douglas DD, Mulligan DC, Harrison ME. Endoscopic treatment of anastomotic biliary strictures after living donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc. 2013 Jan; 77(1):47-54 Epub 2012 Oct 11.
    View PubMed
  55. Carey EJ, Lindor KD. Current pharmacotherapy for cholestatic liver disease. Expert Opin Pharmacother. 2012 Dec; 13 (17):2473-84 Epub 2012 Oct 24
    View PubMed
  56. Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Rakela J, Vargas HE, Moss AA, Mulligan DC, Reddy KS, Chakkera HA. Pretransplant fasting glucose predicts new-onset diabetes after liver transplantation. J Transplant. 2012; 2012:614781 Epub 2012 Jan 29
    View PubMed
  57. Carey EJ, Somaratne K, Rakela J. Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome. Rev Med Chil. 2011 Nov; 139(11):1484-7. Epub 2012 Feb 08.
    View PubMed
  58. Jimenez-Zepeda VH, Heilman RL, Engel RA, Carey EJ, Freeman C, Rakela J, Mulligan DC, Fonseca R, Stewart AK. Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants. Transplantation. 2011 Sep 15; 92(5):570-4.
    View PubMed
  59. Vucicevic D, Carey EJ, Blair JE. Coccidioidomycosis in liver transplant recipients in an endemic area. Am J Transplant. 2011 Jan; 11(1):111-9. Epub 2010 Nov 18.
    View PubMed
  60. Carey EJ, Steidley DE, Aqel BA, Byrne TJ, Mekeel KL, Rakela J, Vargas HE, Douglas DD. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transpl. 2010 Dec; 16(12):1373-8.
    View PubMed
  61. Werner T, Aqel B, Balan V, Byrne T, Carey E, Douglas D, Heilman RL, Rakela J, Mekeel K, Reddy K, Vargas HE. Treatment of hepatitis C in renal transplantation candidates: a single-center experience. Transplantation. 2010 Aug 27; 90 (4):407-11
    View PubMed
  62. Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, De Petris G, Williams JW, Rakela J, Vargas HE. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course. Liver Transpl. 2009 Dec; 15(12):1872-81.
    View PubMed
  63. Singh V, Rudraraju M, Carey EJ, Byrne TJ, Douglas DD, Rakela J, Vargas HE. An unusual occurrence of giant cell hepatitis. Liver Transpl. 2009 Dec; 15(12):1888-90.
    View PubMed
  64. Kim MM, Blair JE, Carey EJ, Wu Q, Smilack JD. Coccidioidal pneumonia, Phoenix, Arizona, USA, 2000-2004. Emerg Infect Dis. 2009 Mar; 15 (3):397-401
    View PubMed
  65. Carey EJ, Vargas HE, Douglas DD, Balan V, Byrne TJ, Harrison ME, Rakela J. Inpatient admissions for drug-induced liver injury: results from a single center. Dig Dis Sci. 2008 Jul; 53 (7):1977-82 Epub 2008 Apr 05
    View PubMed
  66. Rudraraju M, Osowo AT, Singh V, Carey EJ. Do patients need more frequent colonoscopic surveillance after liver transplantation? Transplant Proc. 2008 Jun; 40(5):1522-4.
    View PubMed
  67. Mekeel KL, Moss AA, Reddy KS, Douglas DD, Vargas HE, Carey EJ, Byrne TJ, Harrison ME, Rakela J, Mulligan DC. Living donor liver transplantation in polycystic liver disease. Liver Transpl. 2008 May; 14(5):680-3.
    View PubMed
  68. Carey EJ, Gautam M, Ingall T, Douglas DD. The effect of liver transplantation on autonomic dysfunction in patients with end-stage liver disease. Liver Transpl. 2008 Feb; 14(2):235-9.
    View PubMed
  69. Blair JE, Kusne S, Carey EJ, Heilman RL. The prevention of recrudescent coccidioidomycosis after solid organ transplantation. Transplantation. 2007 May 15; 83(9):1182-7.
    View PubMed
  70. Carey EJ, Leighton JA, Heigh RI, Shiff AD, Sharma VK, Post JK, Fleischer DE. A single-center experience of 260 consecutive patients undergoing capsule endoscopy for obscure gastrointestinal bleeding. Am J Gastroenterol. 2007 Jan; 102: (1)89-95.
    View PubMed
  71. Fry LC, Carey EJ, Shiff AD, Heigh RI, Sharma VK, Post JK, Hentz JG, Fleischer DE, Leighton JA. The yield of capsule endoscopy in patients with abdominal pain or diarrhea. Endoscopy. 2006 May; 38: (5)498-502.
    View PubMed
  72. Carey EJ, Fleischer DE. Investigation of the small bowel in gastrointestinal bleeding--enteroscopy and capsule endoscopy. Gastroenterol Clin North Am. 2005 Dec; 34: (4)719-34.
    View PubMed
  73. Leighton JA, Srivathsan K, Carey EJ, Sharma VK, Heigh RI, Post JK, Erickson PJ, Robinson SR, Bazzell JL, Fleischer DE. Safety of wireless capsule endoscopy in patients with implantable cardiac defibrillators. Am J Gastroenterol. 2005 Aug; 100: (8)1728-31.
    View PubMed
  74. Carey EJ, Douglas DD. Effects of orthotopic liver transplantation on the corrected QT interval in patients with end-stage liver disease. Dig Dis Sci. 2005 Feb; 50 (2):320-3
    View PubMed
  75. Carey EJ, Douglas DD, Balan V, Vargas HE, Byrne TJ, Moss AA, Mulligan DC. Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: a single-center experience. Liver Transpl. 2004 Apr; 10: (4)529-33.
    View PubMed
  76. Carey EJ, Sorbi D. Unsedated endoscopy. Gastrointest Endosc Clin N Am. 2004 Apr; 14: (2)369-83.
    View PubMed
  77. Carey EJ, Heigh RI, Fleischer DE. Endoscopic capsule endoscope delivery for patients with dysphagia, anatomical abnormalities, or gastroparesis. Gastrointest Endosc. 2004 Mar; 59 (3):423-6
    View PubMed
  78. Carey EJ, Sorbi D. Techniques in unsedated endoscopy. Techniques in Gastrointestinal Endoscopy. 2004; 6(2):69-74.
  79. Carey EJ, Balan V, Kremers WK, Hay JE. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem. Liver Transpl. 2003 Nov; 9: (11)1166-73.
    View PubMed
  80. Carey E, Balan V. Metabolic bone disease in patients with liver disease. Curr Gastroenterol Rep. 2003 Feb; 5 (1):71-7
    View PubMed